TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+6.47%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.7B
AUM Growth
+$2.7B
(+4.7%)
Cap. Flow
-$19.8M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
152
New
13
Increased
22
Reduced
28
Closed
8
Top Buys
| 1 |
Merck
MRK
|
$17.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$14.5M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$14.1M |
| 4 |
Novartis
NVS
|
$12.5M |
| 5 |
Biogen
BIIB
|
$12.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$30.3M |
| 2 |
Molina Healthcare
MOH
|
$18.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
$15.5M |
| 4 |
Pfizer
PFE
|
$11.3M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$10.5M |
Sector Composition
| 1 | Healthcare | 91.69% |
| 2 | Real Estate | 3.14% |
